CAMBRIDGE, Mass., April 10, 2023 /PRNewswire/ -- Sumitomo Pharma Oncology, Inc., a clinical-stage company focused on novel…
CAMBRIDGE, Mass., April 10, 2023 /PRNewswire/ -- Sumitomo Pharma Oncology, Inc., a clinical-stage company focused on novel…
CAMBRIDGE, Mass., April 10, 2023 /PRNewswire/ -- Sumitomo Pharma Oncology, Inc., a clinical-stage company focused on novel…
CAMBRIDGE, Mass., April 10, 2023 /PRNewswire/ -- Sumitomo Pharma Oncology, Inc., a clinical-stage company focused on novel…
Published: Apr. 10, 2023 at 7:00 AM CDT|Updated: 14 minutes ago CAMBRIDGE, Mass., April 10, 2023 /PRNewswire/ -- Sumitomo…
TP-1287 was also granted Rare Pediatric Disease Designation from the FDA for the treatment of Ewing sarcoma.
CAMBRIDGE, Mass., April 10, 2023 /PRNewswire/ -- Sumitomo Pharma Oncology, Inc., a clinical-stage company focused on novel…
CAMBRIDGE, Mass., April 10, 2023 /PRNewswire/ -- Sumitomo Pharma Oncology, Inc., a clinical-stage company focused on novel…
CAMBRIDGE, Mass., April 10, 2023 /PRNewswire/ -- Sumitomo Pharma Oncology, Inc., a clinical-stage company focused on novel…
CAMBRIDGE, Mass., April 10, 2023 /PRNewswire/ -- Sumitomo Pharma Oncology, Inc., a clinical-stage company focused on novel…
CAMBRIDGE, Mass., April 10, 2023 /PRNewswire/ -- Sumitomo Pharma Oncology, Inc., a clinical-stage company focused on novel…
CAMBRIDGE, Mass., April 10, 2023 /PRNewswire/ Sumitomo Pharma Oncology, Inc., a clinical-stage company focused on novel cancer…
CAMBRIDGE, Mass., April 10, 2023 /PRNewswire/ -- Sumitomo Pharma Oncology, Inc., a clinical-stage company focused on novel…
CAMBRIDGE, Mass., April 10, 2023 /PRNewswire/ -- Sumitomo Pharma Oncology, Inc., a clinical-stage company focused on novel…
Published: Apr. 10, 2023 at 7:00 AM CDT|Updated: 14 minutes ago CAMBRIDGE, Mass., April 10, 2023 /PRNewswire/ -- Sumitomo…
CAMBRIDGE, Mass., April 10, 2023 /PRNewswire/ -- Sumitomo Pharma Oncology, Inc., a clinical-stage company focused on novel…
CAMBRIDGE, Mass., April 10, 2023 -- Sumitomo Pharma Oncology, Inc., a clinical-stage company focused on novel cancer…
CAMBRIDGE, Mass., April 10, 2023 /PRNewswire/ -- Sumitomo Pharma Oncology, Inc., a clinical-stage company focused on novel…
CAMBRIDGE, Mass., April 10, 2023 /PRNewswire/ -- Sumitomo Pharma Oncology, Inc., a clinical-stage company focused on novel…
CAMBRIDGE, Mass., April 10, 2023 /PRNewswire/ -- Sumitomo Pharma Oncology, Inc., a clinical-stage company focused on novel…
CAMBRIDGE, Mass., April 10, 2023 /PRNewswire/ -- Sumitomo Pharma Oncology, Inc., a clinical-stage company focused on novel…
CAMBRIDGE, Mass., April 10, 2023 /PRNewswire/ -- Sumitomo Pharma Oncology, Inc., a clinical-stage company focused on novel…
, - Sumitomo Pharma Oncology, Inc., a clinical-stage company focused on novel cancer therapeutics, today announced the U.S.
CAMBRIDGE, Mass., April 10, 2023 /PRNewswire/ -- Sumitomo Pharma Oncology, Inc., a clinical-stage company focused on novel…
CAMBRIDGE, Mass., April 10, 2023 /PRNewswire/ -- Sumitomo Pharma Oncology, Inc., a clinical-stage company focused on novel…
CAMBRIDGE, Mass., April 10, 2023 /PRNewswire/ -- Sumitomo Pharma Oncology, Inc., a clinical-stage company focused on novel…
CAMBRIDGE, Mass., April 10, 2023 /PRNewswire/ -- Sumitomo Pharma Oncology, Inc., a clinical-stage company focused on novel…
Published: Apr. 10, 2023 at 7:00 AM CDT|Updated: 6 minutes ago CAMBRIDGE, Mass., April 10, 2023 /PRNewswire/ -- Sumitomo Pharma…
CAMBRIDGE, Mass., April 10, 2023 /PRNewswire/ -- Sumitomo Pharma Oncology, Inc., a clinical-stage company focused on novel…
, - Sumitomo Pharma Oncology, Inc., a clinical-stage company focused on novel cancer therapeutics, today announced the U.S.
CAMBRIDGE, Mass., April 10, 2023 /PRNewswire/ -- Sumitomo Pharma Oncology, Inc., a clinical-stage company focused on novel…
CAMBRIDGE, Mass., April 10, 2023 /PRNewswire/ -- Sumitomo Pharma Oncology, Inc., a clinical-stage company focused on novel…
CAMBRIDGE, Mass., April 10, 2023 /PRNewswire/ -- Sumitomo Pharma Oncology, Inc., a clinical-stage company focused on novel…
CAMBRIDGE, Mass., April 8, 2022 /PRNewswire/ -- Sumitomo Pharma Oncology, Inc., (SMP Oncology) a clinical-stage company focused…
CAMBRIDGE, Mass., April 8, 2022 /PRNewswire/ -- Sumitomo Pharma Oncology, Inc., (SMP Oncology) a clinical-stage company focused…
CAMBRIDGE, Mass., April 8, 2022 /PRNewswire/ -- Sumitomo Pharma Oncology, Inc., (SMP Oncology) a clinical-stage company focused…
CAMBRIDGE, Mass., April 8, 2022 /PRNewswire/ -- Sumitomo Pharma Oncology, Inc., (SMP Oncology) a clinical-stage company focused…
CAMBRIDGE, Mass., April 8, 2022 -- Sumitomo Pharma Oncology, Inc., (SMP Oncology) a clinical-stage company focused on research…
CAMBRIDGE, Mass., April 8, 2022 /PRNewswire/ -- Sumitomo Pharma Oncology, Inc., (SMP Oncology) a clinical-stage company focused…
CAMBRIDGE, Mass., April 8, 2022 /PRNewswire/ -- Sumitomo Pharma Oncology, Inc., (SMP Oncology) a clinical-stage company focused…
CAMBRIDGE, Mass., April 8, 2022 /PRNewswire/ -- Sumitomo Pharma Oncology, Inc., (SMP Oncology) a clinical-stage company focused…
Published: Apr. 8, 2022 at 3:39 PM EDT|Updated: 14 minutes ago CAMBRIDGE, Mass., April 8, 2022 /PRNewswire/ -- Sumitomo Pharma…
Published: Apr. 8, 2022 at 2:39 PM CDT|Updated: 12 minutes ago CAMBRIDGE, Mass., April 8, 2022 /PRNewswire/ -- Sumitomo Pharma…
Published: Apr. 8, 2022 at 3:39 PM EDT|Updated: 12 minutes ago CAMBRIDGE, Mass., April 8, 2022 /PRNewswire/ -- Sumitomo Pharma…
CAMBRIDGE, Mass., April 8, 2022 /PRNewswire/ -- Sumitomo Pharma Oncology, Inc., (SMP Oncology) a clinical-stage company focused…
Published: Apr. 8, 2022 at 3:39 PM EDT|Updated: 10 minutes ago CAMBRIDGE, Mass., April 8, 2022 /PRNewswire/ -- Sumitomo Pharma…
Published: Apr. 8, 2022 at 2:39 PM CDT|Updated: 10 minutes ago CAMBRIDGE, Mass., April 8, 2022 /PRNewswire/ -- Sumitomo Pharma…
Published: Apr. 8, 2022 at 2:39 PM CDT|Updated: 8 minutes ago CAMBRIDGE, Mass., April 8, 2022 /PRNewswire/ -- Sumitomo Pharma…
CAMBRIDGE, Mass., April 8, 2022 /PRNewswire/ -- Sumitomo Pharma Oncology, Inc., (SMP Oncology) a clinical-stage company focused…
Published: Apr. 8, 2022 at 3:39 PM EDT|Updated: 8 minutes ago CAMBRIDGE, Mass., April 8, 2022 /PRNewswire/ -- Sumitomo Pharma…
CAMBRIDGE, Mass., April 8, 2022 /PRNewswire/ -- Sumitomo Pharma Oncology, Inc., (SMP Oncology) a clinical-stage company focused…
CAMBRIDGE, Mass., April 8, 2022 /PRNewswire/ -- Sumitomo Pharma Oncology, Inc., (SMP Oncology) a clinical-stage company focused…
Published: Apr. 8, 2022 at 3:39 PM EDT|Updated: 8 minutes ago CAMBRIDGE, Mass., April 8, 2022 /PRNewswire/ -- Sumitomo Pharma…
Published: Apr. 8, 2022 at 2:39 PM CDT|Updated: 10 minutes ago CAMBRIDGE, Mass., April 8, 2022 /PRNewswire/ -- Sumitomo Pharma…
CAMBRIDGE, Mass., April 8, 2022 /PRNewswire/ -- Sumitomo Pharma Oncology, Inc., (SMP Oncology) a clinical-stage company focused…
Published: Apr. 8, 2022 at 2:39 PM CDT|Updated: 8 minutes ago CAMBRIDGE, Mass., April 8, 2022 /PRNewswire/ -- Sumitomo Pharma…
Published: Apr. 8, 2022 at 3:39 PM EDT|Updated: 7 minutes ago CAMBRIDGE, Mass., April 8, 2022 /PRNewswire/ -- Sumitomo Pharma…
Published: Apr. 8, 2022 at 2:39 PM CDT|Updated: 7 minutes ago CAMBRIDGE, Mass., April 8, 2022 /PRNewswire/ -- Sumitomo Pharma…
Published: Apr. 8, 2022 at 2:39 PM CDT|Updated: 8 minutes ago CAMBRIDGE, Mass., April 8, 2022 /PRNewswire/ -- Sumitomo Pharma…
CAMBRIDGE, Mass., April 8, 2022 -- Sumitomo Pharma Oncology, Inc., (SMP Oncology) a clinical-stage company focused on research…
CAMBRIDGE, Mass., April 8, 2022 /PRNewswire/ -- Sumitomo Pharma Oncology, Inc., (SMP Oncology) a clinical-stage company focused…
CAMBRIDGE, Mass., April 8, 2022 /PRNewswire/ -- Sumitomo Pharma Oncology, Inc., (SMP Oncology) a clinical-stage company focused…
Published: Apr. 8, 2022 at 2:39 PM CDT|Updated: 7 minutes ago CAMBRIDGE, Mass., April 8, 2022 /PRNewswire/ -- Sumitomo Pharma…
CAMBRIDGE, Mass., April 8, 2022 /PRNewswire/ -- Sumitomo Pharma Oncology, Inc., (SMP Oncology) a clinical-stage company focused…
CAMBRIDGE, Mass., April 8, 2022 /PRNewswire/ -- Sumitomo Pharma Oncology, Inc., (SMP Oncology) a clinical-stage company focused…
Published: Apr. 8, 2022 at 3:39 PM EDT|Updated: 5 minutes ago CAMBRIDGE, Mass., April 8, 2022 /PRNewswire/ -- Sumitomo Pharma…
Published: Apr. 8, 2022 at 3:39 PM EDT|Updated: 5 minutes ago CAMBRIDGE, Mass., April 8, 2022 /PRNewswire/ -- Sumitomo Pharma…
Sumitomo Pharma Oncology Presents New Data from Investigational Pipeline of Novel Cancer Therapeutics at AACR Annual Meeting…
Published: Apr. 8, 2022 at 2:39 PM CDT|Updated: 5 minutes ago CAMBRIDGE, Mass., April 8, 2022 /PRNewswire/ -- Sumitomo Pharma…
Published: Apr. 8, 2022 at 3:39 PM EDT|Updated: moments ago CAMBRIDGE, Mass., April 8, 2022 /PRNewswire/ -- Sumitomo Pharma…
CAMBRIDGE, Mass., April 8, 2022 /PRNewswire/ -- Sumitomo Pharma Oncology, Inc., (SMP Oncology) a clinical-stage company focused…
Published: Apr. 8, 2022 at 2:39 PM CDT|Updated: moments ago CAMBRIDGE, Mass., April 8, 2022 /PRNewswire/ -- Sumitomo Pharma…
CAMBRIDGE, Mass., April 8, 2022 /PRNewswire/ -- Sumitomo Pharma Oncology, Inc., (SMP Oncology) a clinical-stage company focused…
CAMBRIDGE, Mass., April 8, 2022 /PRNewswire/ Sumitomo Pharma Oncology, Inc., (SMP Oncology) a clinical-stage company focused on…
CAMBRIDGE, Mass., Nov. 3, 2021 /PRNewswire/ -- Sumitomo Dainippon Pharma Oncology, Inc., a clinical-stage company focused on…
CAMBRIDGE, Mass., Nov. 3, 2021 /PRNewswire/ -- Sumitomo Dainippon Pharma Oncology, Inc., a clinical-stage company focused on…
CAMBRIDGE, Mass., Nov. 3, 2021 /PRNewswire/ -- Sumitomo Dainippon Pharma Oncology, Inc., a clinical-stage company focused on…
Published: Nov. 3, 2021 at 8:00 AM EDT|Updated: 33 minutes ago CAMBRIDGE, Mass., Nov.
Published: Nov. 3, 2021 at 8:00 AM EDT|Updated: 31 minutes ago CAMBRIDGE, Mass., Nov.
Published: Nov. 3, 2021 at 8:00 AM EDT|Updated: 32 minutes ago CAMBRIDGE, Mass., Nov.
Published: Nov. 3, 2021 at 7:00 AM CDT|Updated: 34 minutes ago CAMBRIDGE, Mass., Nov.
CAMBRIDGE, Mass., Nov. 3, 2021 /PRNewswire/ -- Sumitomo Dainippon Pharma Oncology, Inc., a clinical-stage company focused on…
CAMBRIDGE, Mass., Nov. 3, 2021 /PRNewswire/ -- Sumitomo Dainippon Pharma Oncology, Inc., a clinical-stage company focused on…
CAMBRIDGE, Mass., Nov. 3, 2021 /PRNewswire/ -- Sumitomo Dainippon Pharma Oncology, Inc., a clinical-stage company focused on…
CAMBRIDGE, Mass., Nov. 3, 2021 /PRNewswire/ -- Sumitomo Dainippon Pharma Oncology, Inc., a clinical-stage company focused on…
Published: Nov. 3, 2021 at 7:00 AM CDT|Updated: 30 minutes ago CAMBRIDGE, Mass., Nov.
Published: Nov. 3, 2021 at 8:00 AM EDT|Updated: 30 minutes ago CAMBRIDGE, Mass., Nov.
Published: Nov. 3, 2021 at 8:00 AM EDT|Updated: 30 minutes ago CAMBRIDGE, Mass., Nov.
CAMBRIDGE, Mass., Nov. 3, 2021 /PRNewswire/ -- Sumitomo Dainippon Pharma Oncology, Inc., a clinical-stage company focused on…
CAMBRIDGE, Mass., Nov. 3, 2021 /PRNewswire/ -- Sumitomo Dainippon Pharma Oncology, Inc., a clinical-stage company focused on…
Published: Nov. 3, 2021 at 8:00 AM EDT|Updated: 27 minutes ago CAMBRIDGE, Mass., Nov.
Published: Nov. 3, 2021 at 7:00 AM CDT|Updated: 27 minutes ago CAMBRIDGE, Mass., Nov.
Published: Nov. 3, 2021 at 7:00 AM CDT|Updated: 28 minutes ago CAMBRIDGE, Mass., Nov.
Published: Nov. 3, 2021 at 2:00 AM HST|Updated: 29 minutes ago CAMBRIDGE, Mass., Nov.
Published: Nov. 3, 2021 at 7:00 AM CDT|Updated: 29 minutes ago CAMBRIDGE, Mass., Nov.
Published: Nov. 3, 2021 at 8:00 AM EDT|Updated: 26 minutes ago CAMBRIDGE, Mass., Nov.
Published: Nov. 3, 2021 at 7:00 AM CDT|Updated: 26 minutes ago CAMBRIDGE, Mass., Nov.
CAMBRIDGE, Mass., Nov. 3, 2021 /PRNewswire/ -- Sumitomo Dainippon Pharma Oncology, Inc., a clinical-stage company focused on…
CAMBRIDGE, Mass., Nov. 3, 2021 /PRNewswire/ -- Sumitomo Dainippon Pharma Oncology, Inc., a clinical-stage company focused on…